美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lite Strategy Inc.

3.17

+0.10003.26%

盘后：3.180.0098+0.31%17:13 EDT

成交量：109.63万

成交额：346.87万

市值：1.04亿

市盈率：-0.67

高：3.23

开：2.98

低：2.98

收：3.07

52周最高：9.00

52周最低：1.46

股本：3,283.77万

流通股本：3,165.72万

量比：0.31

换手率：3.46%

股息：- -

股息率：- -

每股收益(TTM):-4.7521

每股收益(LYR):2.67

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):1.19

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Lite Strategy Inc.

交易所：

NASDAQ

成立时间：

2000

员工人数：

28

公司地址：

9920 Pacific Heights Blvd.,Suite 150,San Diego,California,United States

官网：

http://www.meipharma.com

邮编：

92121

电话：

传真：

- -

简介：

MEI Pharma, Inc.是一家临床阶段的制药公司，致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道，并通过临床开发、战略合作伙伴关系以及外包许可或商业化（视情况而定）在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。

董事

名称

职位

Frederick W. Driscoll

Chairman of the Board

Nicholas R. Glover

Independent Director

Thomas C. Reynolds

Independent Director

Charlie Lee

Director

Joshua Riezman

Director

股东

名称

职位

Justin J. File

Acting Chief Executive Officer, Chief Financial Officer and Corporate Secretary

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LITS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LITS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LITS\",,,,,undefined,":{"symbol":"LITS","market":"US","secType":"STK","nameCN":"Lite Strategy Inc.","latestPrice":3.17,"timestamp":1757620800000,"preClose":3.07,"halted":0,"volume":1096299,"hourTrading":{"tag":"盘后","latestPrice":3.1798,"preClose":3.17,"latestTime":"17:13 EDT","volume":3707,"amount":11933.589228,"timestamp":1757625239402},"delay":0,"floatShares":31657199,"shares":32837700,"eps":-4.752063,"marketStatus":"盘后交易","change":0.1,"latestTime":"09-11 17:25:01 EDT","open":2.98,"high":3.23,"low":2.98,"amount":3468676.8804119998,"amplitude":0.081433,"askPrice":3.28,"askSize":500,"bidPrice":3.2,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-4.752063,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1757635200000},"marketStatusCode":4,"adr":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":3.07,"preHourTrading":{"tag":"盘前","latestPrice":3.2,"preClose":3.07,"latestTime":"09:29 EDT","volume":152376,"amount":480844.0749168,"timestamp":1757597390017},"postHourTrading":{"tag":"盘后","latestPrice":3.1798,"preClose":3.17,"latestTime":"17:13 EDT","volume":3707,"amount":11933.589228,"timestamp":1757625239402},"volumeRatio":0.313418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LITS\",,,,,undefined,":{"symbol":"LITS","floatShares":31657199,"roa":"--","roe":"--","lyrEps":2.668167,"volumeRatio":0.313418,"shares":32837700,"dividePrice":0,"high":3.23,"amplitude":0.081433,"preClose":3.07,"low":2.98,"week52Low":1.46,"pbRate":"--","week52High":9,"institutionHeld":0.0392,"latestPrice":3.17,"committee":-0.960784,"eps":-4.752063,"divideRate":0,"volume":1096299,"delay":0,"ttmEps":-4.752063,"open":2.98,"prevYearClose":2.46,"prevWeekClose":4.23,"prevMonthClose":4.86,"prevQuarterClose":2.47,"fiveDayClose":4.27,"twentyDayClose":5.14,"sixtyDayClose":2.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LITS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"LITS","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-02-12","symbol":"LITS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-11-12","symbol":"LITS","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.2},{"market":"US","date":"2024-09-19","symbol":"LITS","fiscalQuarterEnding":"2024/06","expectedEps":-1.48,"name":null,"time":"盘后","type":"earning","dateTimestamp":1726718400000,"reportTimeType":"post","actualEps":-1.13},{"market":"US","date":"2024-05-09","symbol":"LITS","fiscalQuarterEnding":"2024/03","expectedEps":-1.38,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LITS\",market:\"US\",,,undefined,":[{"executeDate":"2023-11-16","recordDate":"2023-11-17","paymentDate":"2023-12-06","value":1.75,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LITS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2214205,"yearFounded":2000,"employeeNum":28,"address":"9920 Pacific Heights Blvd.,Suite 150,San Diego,California,United States","zipCode":"92121","officePhone":"858 369 7100"},"stockCompanyDetail":{"websiteUrl":"http://www.meipharma.com","compareEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.0256},{"period":"3month","weight":0.0803},{"period":"6month","weight":0.1588},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.1128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MEI Pharma, Inc.是一家临床阶段的制药公司，致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道，并通过临床开发、战略合作伙伴关系以及外包许可或商业化（视情况而定）在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。","exchange":"NASDAQ","name":"Lite Strategy Inc.","nameEN":"Lite Strategy Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LITS\",market:\"US\",,,undefined,":{"directors":[{"name":"Frederick W. Driscoll","position":"Chairman of the Board"},{"name":"Nicholas R. Glover","position":"Independent Director"},{"name":"Thomas C. Reynolds","position":"Independent Director"},{"name":"Charlie Lee","position":"Director"},{"name":"Joshua Riezman","position":"Director"}],"executives":[{"name":"Justin J. File","position":"Acting Chief Executive Officer, Chief Financial Officer and Corporate Secretary"}]}}}